Variant report
Variant | nsv969046 |
---|---|
Chromosome Location | chr5:49915707-49926436 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:14)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:14 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr5:49926200-49926215 | GM20000 | blood: | n/a | n/a |
2 | CTCF | chr5:49922742-49922790 | GM10266 | blood: | n/a | n/a |
3 | EP300 | chr5:49918079-49918279 | K562 | blood: | n/a | chr5:49918159-49918173 |
4 | FOS | chr5:49919598-49919900 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | FOS | chr5:49919589-49919898 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | FOS | chr5:49919596-49919900 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | FOS | chr5:49919597-49919900 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | GATA2 | chr5:49917947-49918236 | K562 | blood: | n/a | chr5:49918151-49918161 chr5:49918145-49918166 chr5:49918152-49918161 |
9 | RCOR1 | chr5:49918002-49918367 | K562 | blood: | n/a | n/a |
10 | RCOR1 | chr5:49917999-49918195 | K562 | blood: | n/a | n/a |
11 | SPI1 | chr5:49918099-49918412 | HL-60 | blood: | n/a | chr5:49918176-49918189 |
12 | SPI1 | chr5:49918081-49918216 | K562 | blood: | n/a | chr5:49918176-49918189 |
13 | TCF12 | chr5:49923339-49923550 | HepG2 | liver: | n/a | n/a |
14 | TEAD4 | chr5:49918018-49918284 | K562 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000213956 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574721330 | chr5:49915708-49915709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs540412965 | chr5:49915720-49915721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs559857608 | chr5:49915749-49915750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs532075108 | chr5:49915773-49915774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs545787762 | chr5:49915816-49915817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs562304230 | chr5:49915836-49915837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs531649479 | chr5:49915877-49915878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs548155882 | chr5:49915898-49915899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs181868985 | chr5:49915900-49915901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs34426073 | chr5:49915907-49915908 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs547602897 | chr5:49915917-49915918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs146471666 | chr5:49915948-49915949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs567015559 | chr5:49915993-49915994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs186507217 | chr5:49916024-49916025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs138376002 | chr5:49916026-49916027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs188738936 | chr5:49916123-49916124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs532212203 | chr5:49916146-49916147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs569132365 | chr5:49916154-49916155 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs181218546 | chr5:49916192-49916193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs544418852 | chr5:49916213-49916214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs369554251 | chr5:49916214-49916215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs574783202 | chr5:49916221-49916222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs10041633 | chr5:49916229-49916230 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs148914660 | chr5:49916236-49916237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs143590713 | chr5:49916309-49916310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs545545249 | chr5:49916327-49916328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs562525206 | chr5:49916357-49916358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs530205636 | chr5:49916388-49916389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs542459321 | chr5:49919418-49919419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs552700285 | chr5:49919419-49919420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs34219853 | chr5:49919420-49919421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs138826662 | chr5:49919422-49919423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs549988959 | chr5:49919423-49919424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs181017538 | chr5:49919445-49919446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs187375072 | chr5:49919447-49919448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs543445715 | chr5:49919482-49919483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs564059348 | chr5:49919493-49919494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs529568517 | chr5:49919504-49919505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs549609029 | chr5:49919529-49919530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs191796925 | chr5:49919540-49919541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs73095056 | chr5:49919577-49919578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs551483059 | chr5:49919593-49919594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs6888147 | chr5:49919619-49919620 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
44 | rs117300538 | chr5:49919653-49919654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs182425804 | chr5:49919666-49919667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs567226260 | chr5:49919693-49919694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs536097868 | chr5:49919702-49919703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs535611999 | chr5:49919754-49919755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs185955397 | chr5:49919795-49919796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs377201724 | chr5:49925432-49925433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21364760 | CNVD |
Oral cancer | 21386901 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:49915600-49916400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
2 | chr5:49919400-49919800 | Enhancers | Stomach Mucosa | stomach |
3 | chr5:49919600-49919800 | Enhancers | Pancreas | Pancrea |
4 | chr5:49925400-49925600 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
5 | chr5:49925800-49927400 | Weak transcription | Primary T helper naive cells fromperipheralblood | blood |
6 | chr5:49926400-49934200 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |